RE:RE:RE:RE:RE:RE:RE:RE:thumbs up for the new topsI think this is a very intelligent move by the management to utilize the perceived relationship that Canada has globally as a trading partner. If anything, I have to believe (as a US citizen) that the Canadian governent welcomes this relationship of Therelase and China. Whether we like it or not, Theralase is representing Canada, and more importantly especially now....not the US.
With all that is going on "politicallly" in the US, notoriety and acceptance of such cancer technology can accelarate past the US protocols. Is there a risk of intellectual sabatage? Technologically the bounderies of thievery almost don't exist. There will always be risk in that regard. I think the patent acceptance speaks volumes way beyond the patent itself. For China, such cancer technology is an opportunity to represent a global leadership in fighting diseases that are globally common to us all. And that coincides with the fact that they are, if not already, the dominant global economic force that is therefore capable of accelerating the visibility of Therelase much further than we realize.
Perhaps a more constructive point is that this Chinese acceptance of the intellectual property is an acceptance of the global intellectual community of cancer research. It is a welcome mat, if you will, that the Chinese government (however improbable as this may sound) wants to depoliticize such a global technological need.
Could it be that China wants not to be known as some type of technological thief? What greater arena than to accomplish this than in the global fight against cancer.
Let me ask anyone.....should Therelase accept a huge grant from the Chinese government? In order to answer that question, I know that I must first get past my stereo types.